Behavioral and biologic evidence of persistent high-risk behavior in an HIV primary care population

AIDS

Volumn 14, Issue 3, 2000, Pages 297-301

  Erbelding, Emily J ^a,b   Stanton, David ^b   Quinn, Thomas C ^a   Rompalo, Anne ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Chlamydia; Gonorrhea; High risk behavior; HIV; Sexually transmitted diseases; STD

Indexed keywords

CD4 ANTIGEN;

ADULT; AGE; ARTICLE; CHLAMYDIASIS; CONDOM; FEMALE; GENDER; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; SYMPTOMATOLOGY; VIRUS LOAD;

ADULT; CHLAMYDIA INFECTIONS; FEMALE; GONORRHEA; HIV INFECTIONS; HUMANS; MALE; PRIMARY HEALTH CARE; RISK-TAKING; SEXUAL BEHAVIOR; URBAN POPULATION;

EID: 0034052108     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200002180-00012     Document Type: Article

References (13)

1. 1. Institute of Medicine (US) Committee on Prevention and Control of Sexually Transmitted Diseases. The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Washington, DC: National Academy Press 1997: 49-53.
2. 2. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997, 349:1868-1873.
3. 3. Ghys PD, Fransen K, Diallo MO et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 1997, 11:F85-F93.
4. 4. Cohen CR, Sinei S, Reilly M, et al. Effect of human immunodeficiency virus type 1 infection upon acute salpingitis: a laporoscopic study. J Infect Dis 1998, 178:1352-1358.
5. 5. Zhang H, Dornadula G, Beumont M, et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 1998, 339:1803-1809.
6. 6. Chernesky MA, Lee H, Quinn TC, et al. Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first void urine in a ligase chain reaction assay. J Infect Dis 1994, 170:1308-1311.
7. 7. Ching S, Lee H, Hook EW III, et al. Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabs. J Clin Microbiol 1995, 33:3111-3114.
8. 8. Hecht FM, Grant RM, Petropoulos CJ, et al. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med 1998, 339:307-311.
9. 9. Bartlett, JG. Laboratory testing. In: 1999 Medical Management of HIV Infection. Baltimore, MD: Johns Hopkins University Division of Infectious Diseases; 1999:17-44.
10. 10. Anderson JE, MCCormick L, Fichtner R. Factors associated with self-reported STDs: data from a national survey. Sex Transm Dis 1994, 21:303-308.
11. 11. Centers for Disease Control and Prevention, Division of STD Prevention. Sexually Transmitted Disease Surveillance, 1997. Atlanta, GA: US Department of Health and Human Services, Public Health Service; 1998.
12. 12. Catchpole MA, Mercey DE, Nicoll A, et al. Continuing transmission of sexually transmitted diseases among patients infected with HIV-1 attending genitourinary medicine clinics in England and Wales. Br Med J 1996, 312:539-542.
13. 13. Kalichman SC, Greenberg J, Abel GG. HIV-seropositive men who engage in high-risk sexual behaviour: psychological characteristics and implications for prevention. AIDS Care 1997, 9: 441-450.